Cephalalgia

Article	Citations
Visual snow syndrome or “what's in a name?”	104
Cutaneous allodynia in pediatric and adolescent patients and their mothers: A comparative study	85
Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-ana	70
Migraine and work – beyond absenteeism: Migraine severity and occupational burnout – A cohort study	69
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine	66
Characterizing opioid use in a Dutch cohort with migraine	58
Glucocorticoid signaling mediates stress-induced migraine-like behaviors in a preclinical mouse model	58
Latent class analysis of migraine associated vestibular-auditory symptoms	57
Other primary headaches: Distinct clinical features and uncertain pathophysiology	56
Abstracts of the 20th Biennial Migraine Trust International Symposium, London UK, 5th to 8th September 2024	50
Distinguishing persistent post-traumatic headache from migraine: Classification based on clinical symptoms and brain structural MRI data	47
The epidemiology of airplane headache: A cross-sectional study on point prevalence and characteristics in 50,000 travelers	46
Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	46
TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine	42
Genome-wide association study reveals susceptibility loci for self-reported headache in a large community-based Asian population	41
Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks	41
Profile of Chinese Cluster Headache Register Individual Study (CHRIS): Clinical characteristics, diagnosis and treatment status data of 816 patients in China	39
Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model	38
Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura	38
Harassment in the headache field: a global web-based cross-sectional survey	35
Letter to the editor regarding “Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic	34
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes	33
Localized and widespread pressure pain hypersensitivity in patients with episodic or chronic migraine: A systematic review and meta-analysis	31
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	31
CORRIGENDUM to ‘Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN’	28

Efficacy of ubrogepant and atogepant in males and females with migraine: A secondary analysis of randomized clinical trials	27
The prevalence of headache disorders in children and adolescents in Iran: a schools-based study	27
The molecular clock gene cryptochrome 1 (CRY1) and its role in cluster headache	27
Comment on “Effect of COVID vaccination on monthly migraine days”	27
Chronification of migraine sensitizes to CGRP in male and female mice	27
COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection	26
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models	26
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports	26
Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response	26
Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families	25
The Jes Olesen awards for the advancement of headache medicine	25
20th Congress of the International Headache Society September 8-12, 2021	25
Effects of cluster headache preventatives on mouse hypothalamic transcriptional homeostasis	25
Epicranial headache part 1: Primary stabbing headache	25
What do people want to know about “Growing Up with Migraine”? Results of a preference survey of people with lived experience to guide future research	24
The prevalence and burden of medication overuse headache in Greece	24
Cephalalgia: a legacy of excellence, a vision for tomorrow	23
Building community and visibility: A year of social media growth for Cephalalgia	23
Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study	22
Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients	22
Questionnaire and structural imaging data accurately predict headache improvement in patients with acute post-traumatic headache attributed to mild traumatic brain injury	22
Indirect costs attributed to headache: A nation-wide survey of an active working population	22
The effect of low dose thyroid replacement therapy in patients with episodic migraine and subclinical hypothyroidism: A randomised placebo-controlled trial	21
Late Breaking Author Index	21
The impact of epigenetic mechanisms in migraine: Current knowledge and future directions	21
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab	21
Diagnostic utility of T2*-weighted GRE in migraine with aura attack. The cortical veins sign	20
Development of a text message-based headache diary in adolescents and children	20
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll	20
The incremental burden and healthcare resource utilization among people with migraine in Europe: Insights from the 2020 European National Health and Wellness Survey	20
Grey matter structure within the visual networks in migraine with aura: multivariate and univariate analyses	19
Treatment patterns and characteristics of headache in patients in Japan: A retrospective cross-sectional and longitudinal analysis of health insurance claims data	19
The time sequence of brain MRI findings in spontaneous intracranial hypotension	19
OnabotulinumtoxinA for primary new daily persistent headache and comparison to chronic migraine	18
Insights from triggers and prodromal symptoms on how migraine attacks start: The threshold hypothesis	18
Cumulative exposure to estrogen may increase the risk of migraine in women	17
A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache	17
International Classification of Headache Disorders-4 – Work in Progress 1	17
Systemic allergic reaction to galcanezumab (emgality): a case report	17
Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases	16
Author Index	16
Time and headache: Insights into timing processes in primary headache disorders for diagnosis, underlying pathophysiology and treatment implications	16
A response: Update on cough, exertional and sex headache	16
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review	15
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	15
Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: A randomized controlled trial	15
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?	15
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	15
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis	15
CLOCK gene circannual expression in cluster headache	15

High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients	15
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19	15
Mesocorticolimbic system abnormalities in chronic cluster headache patients: A neural signature?	15
No change in interictal plasma and salivary CGRP levels in individuals with vestibular migraine corresponding to episodic migraine	15
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial	15
CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine	15
Identification and characterization of migraine in pregnancy: A Norwegian registry-based cohort study	14
Primary headache disorders in Latin America and the Caribbean: A meta-analysis of population-based studies	14
A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients	14
Systemic lupus erythematosus mimicking retinal migraine: a case report	14
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study	14
Comment on ‘'Correlation between endometriosis and migraine features: Results from a prospective case-control study'‘	14
Mutation screening and association analysis of NOTCH3 p.R544C in patients with migraine with or without aura	14
Paroxysmal localized Hyperhidrosis, a case-report: When excessive sweating occurs in combination with severe headaches	14
Altered interictal serum histamine and immunoglobulin E but unchanged tryptase levels in individuals with episodic and chronic migraine	13
Headache characteristics and postoperative course in Chiari I malformation	13
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study	13
Targeting reactive nitroxidative species in preclinical models of migraine	13
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies	13
Depression screening in migraine - A double-edged sword	13
Epicranial headaches part 2: Nummular headache and epicrania fugax	13
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence	13
DNA-methylation and immunological response in medication overuse headache	13
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria	13
Body mass index and migraine in adolescence: A nationwide study	13
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	13
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study	13
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data	12
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study	12
Mechanical sensitivity changes in pericranial muscles after local anesthesia and experimentally induced pain in the temporalis tendon: Implications for headache and facial pain	12
Efficacy of surgical treatment in patients with trigeminal neuralgia secondary to multiple sclerosis: A prospective study of 18 cases with evaluation of outcome and complications by independent evalu	12
What do patients’ efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry	12
If headache has any association with hypertension, it is negative. Evidence from a population-based study in Nepal	12
Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial	12
Naratriptan is as effective as sumatriptan for the treatment of migraine attacks when used properly. A mini-review	12
Time to retire ‘New daily persistent headache’: Mode of onset of chronic migraine and tension-type headache	12
Association between headache frequency and risk for fibromyalgia in patients with migraine	11
Corrigendum to: PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation	11
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis	11
Call for papers	11
Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury	11
Headaches and the use of personal protective equipment in the general population during the COVID-19 pandemic	11
Headache in progressive facial hemiatrophy (Parry-Romberg syndrome): A paradigmatic case and systematic review of the literature	10
Evaluation and treatment of headache associated with moyamoya disease – a narrative review	10
Photophobia and allodynia in persistent post-traumatic headache are associated with higher disease burden	10
The role of cytokines in migraine: A systematic review	10
Methodological challenges in using screening tools for depression in migraine: A systematic review	10
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	10
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	10
Prevalence and clinical features of hemicrania continua in clinic-based studies: A systematic review and meta-analysis	10
Greater occipital nerve block in migraine may have a place in migraine treatment	10
Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial	10
Response to letter to the Editor: Assessing migraine therapeutics	10
Co-morbidity between trigeminal autonomic cephalalgias and complex regional pain syndrome: Two case reports	10
Intravenous fosphenytoin as treatment for acute exacerbation of trigeminal neuralgia: A prospective systematic study of 15 patients	10
Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education in migraine treatment. A systematic review and meta-analysis	10
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review	10
The first prevalence study of primary headaches in adults in a post-conflict area of Serbia	10
Personal view: Modelling pain mechanisms of migraine without aura	10
Corrigendum to “Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials”	9
Weight loss with atogepant during the preventive treatment of migraine: A pooled analysis	9
Assessing migraine therapeutics	9
Board Walk – April 2021	9
Lidocaine aerosol sprayed on oral and/or nasal mucosa for the rescue of acute trigeminal neuralgia exacerbations: A retrospective study	9
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	9
Letter to the editor regarding “Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database”	9
Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications	9
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study	9
Interim analysis of the Registry for Load and Management of Medication Overuse Headache (RELEASE): A multicenter, comprehensive medication overuse headache registry	9
Pediatric screen exposure and school related headache disability	9
New migraine drugs	9
Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers	9
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	9
Response to letter to the editor: “What predicts citation counts and translational impact in headache research? A machine learning analysis”	9
Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial	9
Headache trajectories in children and adolescents with new onset continuous headache	9
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	9
An altered reward system characterizes chronic migraine with medication overuse headache	9
Telemedicine in headache care: A systematic review	9
PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation	8

Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies	8
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	8
The genetics and chronobiology of cluster headache	8
Recovery and long-term outcome after neurosurgical closure of spinal CSF leaks in patients with spontaneous intracranial hypotension	8
Vagus nerve stimulation inhibits cortical spreading depression via glutamate-dependent TrkB activation mechanism in the nucleus tractus solitarius	8
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	8
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists’ diagnostic accuracy	8
A prolactin-dependent sexually dimorphic mechanism of migraine chronification	8
Pain in the temple? Headache, muscle pain or both: A retrospective analysis	8
Reply to “Reassessing partial efficacy or not responding to acute migraine treatment”	8
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	8
Exploring the effects of extracranial injections of botulinum toxin type A on activation and sensitization of central trigeminovascular neurons by cortical spreading depression in male and female rats	8
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study	8
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	8
IHC 2023 Late Breaking Abstracts	7
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks	7
CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis	7
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition	7
IHS Regional Headache Conference abstracts: 2022	7
Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action	7
The SIH-EBP Score: A grading scale to predict the response to the first epidural blood patch in spontaneous intracranial hypotension	7
Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine	7
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine	7
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine	7
Update in the understanding of new daily persistent headache	7
Prolactin in headache and migraine: A systematic review of clinical studies	7
Mechanisms of GTN-induced migraine: Role of NOS isoforms, sGC and peroxynitrite in a migraine relevant mouse model	7
Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study	7
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients	7
The spectrum of indomethacin-responsive headaches in children and adolescents	7
Measuring headache day severity using multiple features in daily diary designs	7
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study	7
Identifying idiopathic intracranial hypertension in a hospital-based chronic headache population: Utility of magnetic resonance imaging, magnetic resonance venography and trans-orbital sonography	7
Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in Japan	7
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks	7
Pediatric-onset trigeminal autonomic cephalalgias: A systematic review and meta-analysis	7
Abnormal electromyographical trigeminal activation through stimulation of the offending artery (Z-L response): An intraoperative tool during microvascular decompression for trigeminal neuralgia	6
Prevalence, natural history and dynamic nature of chronic headache and medication overuse headache in Italy: The SPARTACUS study	6
COVID-19 vaccination elicited de novo and recurrence of cluster headache: A case series	6
KCl-induced repetitive cortical spreading depression inhibiting trigeminal neuronal firing is mediated by 5-HT1B/1D and opioid receptors	6
Migraine and its major subtypes – with and without aura are associated with polygenic scores for autism	6
Microstructural differences in migraine: A diffusion-tensor imaging study	6
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine	6
Comorbidity or combination – more evidence for cluster-migraine?	6
Drugs associated with reversible cerebral vasoconstriction syndrome: A pharmacovigilance study in vigiBase®	6
Neurofilament light chain is elevated in patients with newly diagnosed idiopathic intracranial hypertension: A prospective study	6
Transorbital sonography: A non-invasive bedside screening tool for detection of pseudotumor cerebri syndrome	6
High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A systematic review and meta-analysis	6
Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients	6
Delivery of care for migraine in the Asian Oceanian region: A cross-sectional study	6
Looking at Cephalalgia from the inside	6
The midfacial segment pain: little known disorder in need of scientific evaluation	6
Galcanezumab modulates Capsaicin-induced C-fiber reactivity	6
Board Walk	6
P3 latency as a biomarker for the complexity of migraine with aura: Event-related potential study	6
Pathophysiology of cluster headache: From the trigeminovascular system to the cerebral networks	6
Lack of a direct link between macular cones function and photophobia in interictal migraine	6
Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study	6
The Global Campaign Against Headache and its future relation to IHS and WHO	6
Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions	6
A national Swedish case-control study investigating incidence and factors associated with idiopathic intracranial hypertension	6
A population-health approach to characterizing migraine by comorbidity: Results from the Mindfulness and Migraine Cohort Study	6
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial	6
Artificial intelligence and headache	5
Efficacy and tolerability of 100 mg of lasmiditan for migraine: A multi-center, prospective observational real-world study in Japan	5
Successful treatment of primary headache associated with sexual activity using erenumab: Case report	5
Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine	5
Crossing the Rubicon? The future impact of artificial intelligence on headache medicine	5
The neurotrophic factor artemin and its receptor GFRα3 mediate migraine-like pain via the ion channel TRPM8	5
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®	5
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants	5
Visual snow: A systematic review and a case series	5
Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2	5
Perceived barriers to career progression in the headache field: A global web-based cross-sectional survey	5
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study	5
Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study	5
Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up	5
The non-decussating and decussating trigeminothalamic tracts in humans: A combination of connectome-based tractography and histological validation	5
Unilateral increased visual sensitivity in cluster headache: a cross-sectional study	5
CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine	5
Dysregulation of the peripheral glutamatergic system: A key player in migraine pathogenesis?	5
Sex differences in photophobic behaviors following cortical spreading depression in rats	5
Evaluation of the ICHD-3 diagnostic criteria for cardiac cephalalgia and new proposal	5
Association between iron deficiency anemia and chronic daily headache: A case-control study	5
Quality appraisal of existing guidelines for the management of headache disorders by the AGREE II’s method	5
Micturition-triggered severe headache associated with bladder paraganglioma: A case report	5
Incidence of spontaneous intracranial hypotension in a community: Beverly Hills, California, 2006–2020	5
Migraine and risk of hypertensive disorders of pregnancy: A population-based cohort study	5
No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational study	4
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial	4
Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?	4
Central sensitization mechanisms in chronic migraine with medication overuse headache: a study of thalamocortical activation and lateral cortical inhibition	4
Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine	4
Clinical correlates of hypothalamic functional changes in migraine patients	4
Phenotyping non-idiopathic pseudotumor cerebri syndrome – A prospective cohort study	4